Bayshore HealthCare

bayshore.ca

Bayshore HealthCare has been dedicated to enhancing the quality of life, dignity and independence of Canadians in their homes since 1966. Canadian owned and operated, we are the country's largest provider of home and community health care services, with more than 50 home care offices, 20 community care clinics and 8,000 employees. Offering a wide range of home and community health services, we strive to make a difference in our clients' lives – every visit, every time. Our nursing, personal care, home support and companionship services are available privately as well as through government care programs, personal and group insurance plans and workplace safety insurance. We deliver care to more than 70,000 clients annually.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

ORSINI SPECIALTY PHARMACY SELECTED BY SANOFI AS A LIMITED DISTRIBUTION PARTNER FOR NEXVIAZYME®

Orsini Specialty Pharmacy | September 28, 2021

news image

Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare diseases and gene therapies, announced that Sanofi has selected it as a limited distribution partner for Nexviazyme® (avalglucosidase alfa-ngpt). Nexviazyme, an enzyme replacement therapy (ERT), is used for treating patients one year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). This progressive and debilitating muscle disorder impairs a person's abi...

Read More

Business Insights

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

news image

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More

Business Insights

WUXI STA BREAKS GROUND FOR NEW PHARMACEUTICAL MANUFACTURING FACILITY IN MIDDLETOWN, DELAWARE

WuXi AppTec | August 17, 2022

news image

WuXi STA, a leading Contract Research, Development, and Manufacturing Organization is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware. First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world. The WuXi STA Middletown site is located in the Middletown Bus...

Read More

Business Insights

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

news image

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More
news image

Business Insights

ORSINI SPECIALTY PHARMACY SELECTED BY SANOFI AS A LIMITED DISTRIBUTION PARTNER FOR NEXVIAZYME®

Orsini Specialty Pharmacy | September 28, 2021

Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare diseases and gene therapies, announced that Sanofi has selected it as a limited distribution partner for Nexviazyme® (avalglucosidase alfa-ngpt). Nexviazyme, an enzyme replacement therapy (ERT), is used for treating patients one year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). This progressive and debilitating muscle disorder impairs a person's abi...

Read More
news image

Business Insights

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More
news image

Business Insights

WUXI STA BREAKS GROUND FOR NEW PHARMACEUTICAL MANUFACTURING FACILITY IN MIDDLETOWN, DELAWARE

WuXi AppTec | August 17, 2022

WuXi STA, a leading Contract Research, Development, and Manufacturing Organization is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware. First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world. The WuXi STA Middletown site is located in the Middletown Bus...

Read More
news image

Business Insights

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More

Resources

resource image

Pharma Tech

ValGenesis e-Logbook

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us